Drugs / Ginkgo Diterpene Lactone Meglumine Injection
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05531942 Comparator | Jan 2021 → Oct 2023 | ischemic stroke | Shanghai Yueyang Integrated Medicine Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo Diterpene Lactone Meglumine Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05531942 ↗ |
| Route | Intravenous | “intravenous drip for about 3 hours” NCT05531942 ↗ |